Position in ANEB
as of Dec 31, 2025
· filed Feb 11, 2026
Position Value
$2,275
-$3,070 QoQ
Shares Held
2,253
+5.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 19 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANEB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025JPMORGAN CHASE & CO holds $15,158,182,121 across 390 Biotechnology names. ANEB ranks #312 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
23,199,512 | $4,037,643,062 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,160 | $3,041,291,289 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,039,481 | $2,738,059,096 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,719,999 | $1,876,907,598 | |
| 5 | NUVL |
Nuvalent, Inc.
|
2,205,251 | $221,826,193 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,304,792 | $182,332,089 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,044,642 | $177,589,140 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,423,989 | $152,423,781 |
All Filings in ANEB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $2,275 | 2,253 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,345 | 2,138 | Shares | Defined | 2025-11-26 | |
| 2025-03-31 | $10 | 8 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $15 | 9 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $17 | 9 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $27 | 10 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $25 | 9 | Shares | Defined | 2024-12-26 | |
| 2023-03-31 | $46 | 16 | Shares | Defined | 2023-05-18 | |
| No filing history on record for this holder in this stock. | ||||||